Immune Checkpoint Inhibitor Induced Diabetes Mellitus Treated with Insulin and Metformin: Evolution of Diabetes Management in the Era of Immunotherapy

Immune checkpoint inhibitors (ICPIs) are a breakthrough therapy in oncology and have been approved by the Food and Drug Administration for the treatment of several malignancies. ICPIs have been reported to cause immune-mediated damage of islet cells leading to ICPI-induced type 1 diabetes mellitus (...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Case Rep Oncol Med
Autors principals: Alrifai, Taha, Ali, Faisal Shaukat, Saleem, Sameer, Ruiz, Diana Carolina Miranda, Rifai, Dana, Younas, Sundas, Qureshi, Faisal
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2019
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6875347/
https://ncbi.nlm.nih.gov/pubmed/31781446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8781347
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars